Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (171-180 of 436) with videos related to

Pageof 44
Sort By:
JAMA Internal Medicine|October 5, 2017
Strategies That Delay Market Entry of Generic DrugsKerstin Noëlle Vokinger, Aaron S Kesselheim, Jerry Avorn, et al.
Health Affairs (Project Hope)|January 20, 2017
Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug MakersAaron S Kesselheim, Benjamin N Rome, Ameet Sarpatwari, et al.
The Annals of Pharmacotherapy|January 26, 2012
Comment: generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studiesJoshua J Gagne, Jerry Avorn, William H Shrank, et al.
BMJ (Clinical Research Ed.)|August 20, 2024
Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional studyAriadna Tibau, Thomas J Hwang, Jerry Avorn, et al.
The New England Journal of Medicine|November 19, 2004
Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitorsMichael A Fischer, Sebastian Schneeweiss, Jerry Avorn, et al.
Health Services Research|September 13, 2003
Improved comorbidity adjustment for predicting mortality in Medicare populationsSebastian Schneeweiss, Philip S Wang, Jerry Avorn, et al.
Archives of Internal Medicine|May 22, 2002
Nonsteroidal anti-inflammatory drug use and acute myocardial infarctionDaniel H Solomon, Robert J Glynn, Raisa Levin, et al.
Plos Medicine|March 18, 2015
Paying physicians to prescribe generic drugs and follow-on biologics in the United StatesAmeet Sarpatwari, Niteesh K Choudhry, Jerry Avorn, et al.
JAMA Network Open|November 8, 2022
Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid PatientsMike Z Zhai, Jerry Avorn, Jun Liu, et al.
Contraception|January 26, 2016
Trends in direct-to-consumer advertising of prescription contraceptivesMin H Wu, Deborah Bartz, Jerry Avorn, et al.
Pageof 44

Showing results (171-180 of 436) with videos related to

Sort By:
Pageof 44
JAMA Internal Medicine|October 5, 2017
Strategies That Delay Market Entry of Generic DrugsKerstin Noëlle Vokinger, Aaron S Kesselheim, Jerry Avorn, et al.
Health Affairs (Project Hope)|January 20, 2017
Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug MakersAaron S Kesselheim, Benjamin N Rome, Ameet Sarpatwari, et al.
The Annals of Pharmacotherapy|January 26, 2012
Comment: generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studiesJoshua J Gagne, Jerry Avorn, William H Shrank, et al.
BMJ (Clinical Research Ed.)|August 20, 2024
Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional studyAriadna Tibau, Thomas J Hwang, Jerry Avorn, et al.
The New England Journal of Medicine|November 19, 2004
Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitorsMichael A Fischer, Sebastian Schneeweiss, Jerry Avorn, et al.
Health Services Research|September 13, 2003
Improved comorbidity adjustment for predicting mortality in Medicare populationsSebastian Schneeweiss, Philip S Wang, Jerry Avorn, et al.
Archives of Internal Medicine|May 22, 2002
Nonsteroidal anti-inflammatory drug use and acute myocardial infarctionDaniel H Solomon, Robert J Glynn, Raisa Levin, et al.
Plos Medicine|March 18, 2015
Paying physicians to prescribe generic drugs and follow-on biologics in the United StatesAmeet Sarpatwari, Niteesh K Choudhry, Jerry Avorn, et al.
JAMA Network Open|November 8, 2022
Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid PatientsMike Z Zhai, Jerry Avorn, Jun Liu, et al.
Contraception|January 26, 2016
Trends in direct-to-consumer advertising of prescription contraceptivesMin H Wu, Deborah Bartz, Jerry Avorn, et al.
Pageof 44